Skip to content

A comparative study between intraarticular injection of platelet-rich-plasma and corticosteroid in treatment of mild to moderate knee Osteoarthritis

A comparative study between intraarticular injection of platelet-rich-plasma and corticosteroid in treatment of mild to moderate knee Osteoarthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103588
Enrollment
84
Registered
2026-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: inj kanacort: 2 ml intraarticular knee injection one time injection 15 min for injection Control Intervention1: platelet reach plasma: 5 ml intraarticular knee injection of platelet rea

Sponsors

GMERS MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Knee Osteoarthritis Grade 1 and 2 (Kellgren Lawrence grading) at the OPD of Orthopaedics department of GMERS HOSPITAL,GOTRI and are comparable with respect to Age between 40 to 60 years with unilateral knee pain(OA) Age between 40 to 60 years with bilateral knee pain with severe pain in one knee(OA) Body mass index Pre-injection WOMAC SCORE,VAS SCALE, & KOOS SCORE.

Exclusion criteria

Exclusion criteria: Immunosuppressed patients Patients with secondary osteoarthritis Patients with inflammatory disorder of joints(RA) Patients who have received any intraarticular injections within past 6 months Patients with K/C/O diabetes Patients with tumours, metabolic diseases of bone Patients who underwent knee arthroscopy in last 6 months

Design outcomes

Primary

MeasureTime frame
1 week,6 weeks,3 months, and 6 monthsTimepoint: 1 week,6 weeks,3 months, and 6 months

Secondary

MeasureTime frame
Secondary outcomes included improvement in knee function, reduction in stiffness, and enhancement of quality of life as assessed by validated scoring systems such as WOMAC and VAS. PRP injections demonstrated superior long-term improvement in functional scores and sustained pain reduction compared to corticosteroid injections. Corticosteroids showed earlier symptomatic relief, but effects diminished over time. No major adverse events were reported in either group, indicating both treatments were safe and well tolerated.Timepoint: Based on WOMAC, VAS and KOOS score Scoring System criteria at 1 week,6 weeks,3 months, and 6 months

Countries

India

Contacts

Public ContactBHUMIL CHAMPAKBHAI RATHOD

GMERS MEDICAL COLLEGE AND HOSPITAL VADODARA

bhumilrathod2011@gmail.com09537691969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026